The Iran-Israel conflict has quickly spilled into the global travel industry, triggering flight cancellations, airspace closures, and major disruption across the Middle East.

Missile and drone strikes across Gulf countries have forced airlines to suspend operations and reroute aircraft, leaving thousands of travellers stranded and forcing airlines to rapidly adjust flight paths.

One of the clearest signs of the disruption came when missile debris fell over Dubai’s Palm Jumeirah, a luxury tourism district known for its hotels and restaurants.

The debris sparked a fire that injured four people.

Since Iran launched its retaliatory strikes, more than 27,000 flights have been cancelled worldwide, according to aviation analytics firm Cirium.

Airlines are attempting to navigate restricted airspace and rising security risks across several regional corridors.

Gulf airspace shutdown

The immediate shock to aviation has been the closure or restriction of airspace across parts of the Middle East.

Following US-Israeli attacks on Iran and Tehran’s retaliation, countries across the region imposed limits on commercial flights and tightened aviation security.

These restrictions disrupted major aviation corridors linking Asia, Europe, and Africa.

Key transit hubs such as Dubai, Abu Dhabi, and Doha saw cancellations and operational delays as airlines adjusted schedules.

Dubai International Airport alone handled a record 95.2 million passengers in 2025, making it the busiest hub for international travel.

When operations slowed there, the ripple effects quickly spread across global airline networks.

Airlines also faced operational challenges as aircraft and crews ended up in the wrong locations, making it difficult to quickly restore normal flight schedules and reposition fleets across continents.

Travellers stranded across Gulf

The aviation disruption has left many travellers stranded across the region.

Government-organised repatriation flights have been arranged to help people return home, but delays continue as airlines work through the backlog.

Reports indicate that hundreds of thousands of travellers were affected as airlines cancelled flights connecting the Middle East with Europe, Asia, and North America.

Some passengers have turned to expensive alternatives, including charter flights from Dubai to Europe costing more than $200,000.

Cruise operator MSC Cruises also changed its plans after the conflict disrupted operations.

The company cancelled its remaining March sailings from Dubai.

It also arranged five charter flights to repatriate passengers from its MSC Euribia ship, which remained docked in the city after the conflict escalated.

Tourism hubs under pressure

The disruption is particularly significant for Gulf economies that rely heavily on tourism and aviation.

Tourism accounted for about 12% of the United Arab Emirates’ economy in 2023, highlighting how closely the sector is tied to the region’s economic activity.

Airlines, including Emirates, Etihad Airways, and FlyDubai, have begun restoring limited operations through a designated safe air corridor, allowing up to 48 flights per hour while authorities monitor the security situation.

Even as flights slowly resume, airlines and tourism authorities face the challenge of reassuring travellers that the region remains safe for international travel.

They must also convince passengers that aviation networks can stabilise after the sudden disruption.

According to experts, restoring passenger confidence will be critical for the sector’s recovery.

The post How Iran Israel conflict is shaking Middle East airlines, global tourism appeared first on Invezz

Indian paint companies are facing renewed pressure as rising crude oil prices, softer demand trends, and intensifying competition weigh on the sector’s outlook.

Shares of major paint manufacturers have declined sharply in recent trading sessions, reflecting concerns that higher input costs and slowing consumption could squeeze profitability.

The sector’s vulnerability stems largely from its heavy reliance on crude-linked raw materials.

With geopolitical tensions pushing oil prices higher, analysts say paint companies may struggle to maintain margins while balancing price increases and demand risks.

Rising crude prices squeeze margins

Crude oil derivatives account for roughly half of paint manufacturers’ raw material costs, including solvents, resins and emulsions.

As global oil prices rise, these input costs increase, putting immediate pressure on profit margins.

The recent surge in crude prices followed escalating tensions in the Middle East after joint US and Israeli strikes on Iran triggered retaliation and concerns about disruptions to global energy supply.

Brent crude futures rose sharply by 25% in the week, climbing above $90 per barrel in the week. West Texas Intermediate crude also surged, jumping more than 32% to around $88 per barrel.

The escalation raised concerns about the Strait of Hormuz, one of the world’s most important oil transit routes.

Nearly 20% of global oil flows and more than 40% of India’s crude imports pass through the narrow waterway.

According to consultancy Wood Mackenzie, a prolonged disruption could push oil prices above $100 per barrel if tanker flows are not quickly restored.

For India, which imports about 85% of its crude oil requirements, higher energy prices create a significant ripple effect across industries that rely heavily on petrochemical inputs, including the paint sector.

Higher input costs can compress gross margins and force companies to consider price increases, which in turn may affect demand.

Paint stocks fall amid industry concerns

Investor concerns about these pressures have already been reflected in the stock market.

Shares of several major paint companies dropped sharply as crude prices surged.

Berger Paints fell about 7% in the last month, while Asian Paints and Akzo Nobel India slipped 5%, Kansai Nerolac Paints plunged 11%, and Shalimar Paints nosdived more than 14%.

Brokerage firm HSBC said rising input costs could force paint makers to increase prices selectively, though the ability to pass on costs may be limited.

HSBC maintained a “hold” rating on Asian Paints but lowered its target price to ₹2,600 from ₹2,900.

It also kept a “hold” rating on Berger Paints while reducing the target price to ₹500 from ₹540, citing moderated margin expectations.

The brokerage noted that the market structure has evolved since earlier inflation cycles, making it more difficult for companies to protect margins.

Even as companies attempt price hikes to offset higher costs, competition in the sector remains intense.

Analysts say these structural changes could limit the effectiveness of pricing actions compared with past periods of inflation.

Demand trends add further pressure

Beyond cost pressures, the sector is also grappling with changes in consumer behaviour.

Industry growth has slowed as discretionary spending patterns shift, with more consumers allocating budgets to travel and hospitality rather than home improvement projects.

People are also seemingly painting less of their homes according to paint company executives.

“Growth has periods of cyclicity. While the CAGR remains strong, we are seeing some changes in consumption trends. The frequency of painting has slowed down. Occasion-led painting has reduced; for example, more people are opting for destination weddings rather than home-based weddings, which leads to a postponement of painting. Since painting is a discretionary spend, people are currently investing more in travel and hospitality,” Amit Singhal, MD & CEO Asian Paints said in a recent earnings call.

Demand patterns have also diverged between rural and urban markets. Rural areas performed relatively better in recent months due to favourable rainfall and improved sentiment.

Brokerage CLSA warned that companies across consumer sectors could face margin pressure if crude-linked costs continue to rise and firms cannot fully pass these increases on to consumers.

Higher inflation could also weaken discretionary spending, slowing demand for products such as paints and other home improvement goods.

In this environment, paint companies may face a difficult balancing act: managing rising raw material costs while navigating subdued demand and competitive pressures in a rapidly evolving market.

The post Indian paint stocks slump as crude surge, weak demand hit margins appeared first on Invezz

Mounting redemption requests across private credit funds are raising fresh questions about the resilience of one of the fastest-growing corners of the global debt market.

BlackRock, the world’s largest asset manager, has limited withdrawals from one of its flagship private credit vehicles for the first time, underscoring growing investor unease as volatility spreads across financial markets.

Shares of BlackRock fell about 7% in late morning trading, hitting their lowest level since May, after the firm said its HPS Corporate Lending Fund would stick to its plan to repurchase only up to 5% of shares this quarter, approximately representing $620 million, despite receiving significantly higher redemption requests.

The fund, known by its ticker HLEND, received requests to redeem 9.3% of its shares during the latest quarter, according to a letter sent to investors on Friday.

It marked the first time since the fund’s launch four years ago that redemption requests exceeded its quarterly limit.

Liquidity limits highlight structural mismatch

The decision highlights a key feature of many private credit vehicles: limited liquidity.

Unlike public bond funds, private credit portfolios typically consist of loans to midsize companies that cannot be quickly sold in open markets.

Managers argue that such limits are essential to preserving returns and avoiding forced asset sales.

HLEND has generated an annualized return of about 10.7% after fees since inception, according to the fund’s managers, who said the capped redemption structure is designed to match investor capital with the long-term nature of private loans.

“HLEND’s intentionally designed liquidity framework, specifically the recurring 5% quarterly share repurchase feature, is foundational to enabling these return outcomes,” the managers said in their letter to investors.

Without such limits, they argued, the fund could face a structural mismatch between investor withdrawal requests and the duration of the loans held in its portfolio.

Investor anxiety grows across the sector

BlackRock’s move comes as investor sentiment toward private credit has begun to deteriorate following years of rapid growth.

Earlier this week, rival Blackstone faced record withdrawal requests from its massive $82 billion private credit fund BCRED.

In response, the firm temporarily raised its redemption limit from the usual 5% to about 7% and deployed roughly $400 million of capital from the company and its employees to meet all withdrawal requests.

The contrasting responses illustrate the pressure facing fund managers as investors reassess risks in the asset class.

Blue Owl recently replaced redemption payments with promises of future payouts, adding to concerns about liquidity in the sector.

At the same time, a series of high-profile defaults — including the bankruptcies of a US auto parts supplier and a subprime auto lender — has raised questions about credit quality within some private lending portfolios.

Booming industry faces first major test

Private credit has expanded rapidly over the past decade as lenders stepped in to fill gaps left by banks retreating from corporate lending following the global financial crisis.

The industry now manages trillions of dollars globally, providing direct loans to companies outside traditional syndicated bond markets.

While pension funds and insurers remain the largest investors, wealthy individuals have increasingly poured money into so-called semi-liquid funds that allow periodic redemptions within capped limits.

However, the current wave of redemption requests marks one of the first major tests for these structures.

Market volatility, concerns about a potential economic slowdown and geopolitical tensions have pushed some investors toward safer assets, prompting attempts to withdraw funds tied up in longer-term private loans.

BlackRock has been expanding its presence in private markets as part of a broader strategy to boost fee income.

The firm completed the acquisition of HPS Investment Partners last year in a bid to strengthen its private credit capabilities.

But the surge in redemption requests suggests that after years of record fundraising and strong returns, the private credit boom may be entering a more challenging phase as investors reassess liquidity risks and credit quality.

The post BlackRock limits withdrawals as private credit redemptions surge appeared first on Invezz

Day One Biopharmaceuticals (NASDAQ: DAWN) ripped higher on Friday morning after Servier signed a definitive agreement to acquire the California-based firm for about $2.5 billion in cash.

Servier’s deal rewrites DAWN’s technical profile, valuing its shares at $21.5 each, which translates to a nearly 70% upside from its previous close.

Following this explosive move to the upside, Day One Biopharmaceuticals’ stock is trading at more than twice its price at the start of this year (2026).

Why is Servier announcement positive for DAWN stock?

The Servier announcement is being hailed as a “best-case scenario” for DAWN stock as it validates the immense value of Day One’s lead programme Ojemda (tovorafebin).

Ojemda is the company’s “breakthrough” treatment for pediatric low-grade glioma.

For a mid-cap biotech name, securing a multi-billion-dollar exit during a complex regulatory environment provides immediate liquidity.

It also removes the commercialization risk that often plagues independent biotech firms attempting to scale specialized oncology drugs alone.

All in all, the Servier deal positions Day One Biopharmaceuticals within a global oncology framework that enhances its credibility with regulators and institutional investors.

Is there any upside left in Day One Biopharmaceuticals shares

While the Servier agreement is evidently positive for Day One Pharmaceuticals shares, for investors looking to jump in now, the window of opportunity for significant gains has likely slammed shut.

With the biotech stock already trading at roughly $21.50, the market has already priced in the vast majority of the deal’s value.

In the world of mergers and acquisitions (M&A), a stock trading so close to its buyout price signals high confidence that the deal will close as planned in the second quarter.

Unless a bidding war erupts – which analysts deem unlikely given the specific niche of pediatric oncology – there’s no fundamental reason for Day One Biopharmaceuticals to move higher.

In short, new capital faces “capped” upside with potential downside risk if the deal hits regulatory snags.

What to expect from Day One moving forward

Ultimately, the Day One acquisition marks a significant milestone for the biotech sector in 2026, signaling that high-quality, targeted oncology assets remain in high demand.

For those who were already holding DAWN shares, this 65% jump is a well-deserved reward for weathering previous volatility.

However, for prospective buyers, the risk-reward ratio has shifted unfavorably.

With the “deal premium” fully baked into the current price and no signs of a competing bidder on the horizon, the smart money is likely looking toward the next potential takeover target rather than chasing this peak.

The Day One Biopharmaceuticals Inc story has reached a successful, albeit final, chapter for public investors.

But for the broader biotech landscape, the transaction underscores that strategic buyers remain willing to pay premiums for differentiated oncology assets, reinforcing sector confidence despite volatility.

The post Is there any upside left in DAWN stock as it soars 65%? appeared first on Invezz

Micron Technology shares fell on Friday as weakness in South Korean memory names weighed on sentiment and US investors awaited February jobs data.

The moves come as US stocks remained in the red amid the Iran conflict, while South Korean memory giants Samsung Electronics and SK Hynix also declined on the Korea Exchange.

Micron edges lower with global memory sentiment

Micron, a major producer of DRAM and NAND chips, traded 2% lower at $389.12.

In Seoul, Samsung Electronics fell 1.77% to 188,200 won and SK Hynix dropped 1.81% to 924,000 won.

CNBC’s Jim Cramer warned earlier this week about “South Korean spillover into our markets,” naming Micron among stocks he called “all still vulnerable.”.

Technical setup and near-term catalyst

Despite a 12-month gain of 344.77%, Micron is trading 4% below its 20-day simple moving average of $406.13, while remaining 29.8% above its 100-day SMA of $300.60.

Its RSI reads 50.31, indicating neutral momentum.

The company reports earnings on March 18. Street estimates call for EPS of $8.56, up from $1.56 year over year, and revenue of $19.10 billion, up from $8.05 billion year over year.

Analyst views and valuation

Micron carries a Buy rating with an average price target of $377.

Recent moves include UBS raising its target to $475 on March 2, Stifel lifting to $550 on March 2, and Needham increasing to $450 on February 17.

A price-to-earnings multiple of 37.7x reflects a premium valuation ahead of earnings.

Western Digital’s rebound and risks

Western Digital, a provider of HDDs, SSDs, and flash memory, has seen business conditions improve as the storage cycle turns up and revenue growth returns to positive.

The stock is up about 60% year-to-date, and a recent earnings analysis cited by Seeking Alpha argues the rally could extend, with potential upside of 40% over the next 12 months.

The company has navigated supply challenges tied to the semiconductor shortage by diversifying its supply chain and expanding capacity, while benefiting from demand tied to AI and cloud computing.

Momentum, multiples, and concentration

The cloud-driven revenues now dominate Western Digital’s mix and margins have surged post-downturn.

Valuation is elevated at 27x EV/EBITDA (TTM) and 7.2x EV/Sales, reflecting expectations for durable AI and hyperscale demand.

Customer concentration is a key risk, with three clients accounting for 46% of H1 FY26 revenue, exposing results to hyperscaler deployment cycles.

The analysis initiates the stock at Hold, arguing that current multiples price in near-perfect execution that may be difficult to sustain in a historically cyclical industry.

The takeaway

Micron’s dip underscores how South Korean memory moves can ripple into US trading, just as a closely watched earnings report approaches with sharply higher estimates.

Western Digital’s rebound illustrates the sector’s improving cycle and AI-driven demand, but elevated valuations and customer concentration leave little room for disappointment.

The post Micron stock falls as weakness hits global memory sector appeared first on Invezz

Shares of Novo Nordisk fell sharply after the company said its next-generation obesity drug CagriSema delivered weaker weight-loss results than a rival treatment from Eli Lilly and Company.

Novo said on Monday that patients treated with a standard dose of CagriSema achieved average weight loss of 20.2% after 84 weeks, compared with 23.6% for Lilly’s tirzepatide.

Following the announcement, Novo shares plunged as much as 15.4% in Copenhagen trading, while Lilly shares rose as much as 4.2% in premarket US trading.

Although Novo said the trial showed that CagriSema appeared safe and well-tolerated, market reaction reflected disappointment over its relative effectiveness.

Primary endpoint missed

Novo said the trial failed to meet its primary endpoint of demonstrating non-inferiority in weight loss compared with tirzepatide after 84 weeks.

The company acknowledged in its Monday statement that CagriSema did not match Lilly’s treatment’s performance, marking another setback in its efforts to defend its position in the rapidly growing obesity drug market.

Tirzepatide is the active ingredient in Lilly’s blockbuster medicines Mounjaro and Zepbound, which have overtaken Novo’s semaglutide-based drugs Ozempic and Wegovy in US prescriptions.

The latest results could limit CagriSema’s commercial potential at a time when Novo is under pressure to regain lost market share.

Strategic importance of CagriSema

CagriSema has been positioned as a central element of Novo’s long-term obesity strategy, particularly as newer, more powerful treatments enter the market and patents for Wegovy and Ozempic approach expiry.

The injection combines semaglutide with cagrilintide, a compound that mimics the gut hormone amylin.

The combination was designed to enhance appetite suppression and improve weight-loss outcomes.

Colin White, an analyst at UBS, wrote in a note before the results that the base-case expectation was that CagriSema would at least not perform worse than Zepbound.

“The base case for the trial was that the newer Novo drug wouldn’t be worse than Zepbound,” White said.

The outcome, therefore, represents a clear disappointment relative to those earlier expectations.

Management changes and market pressure

The trial setback comes against the backdrop of significant internal changes at Novo.

Over the past year, the company has replaced its chief executive and experienced board-level departures amid concerns over competitive performance.

Former head of international operations Mike Doustdar was elevated to chief executive after the departure of the previous CEO.

Since taking over, Doustdar has announced thousands of job cuts and ordered staff back to the office in an effort to restore performance standards.

He also pursued an unsuccessful bid for obesity start-up Metsera, losing out to Pfizer.

Doustdar has since said Novo will go “very big” in its search for future obesity deals.

Novo shares have fallen more than 58% over the past 12 months, reducing the company’s market value to around $189 billion.

In 2024, the company was briefly valued at more than $600 billion.

The company is also exploring additional trials, including higher-dose combinations, to improve outcomes. Novo said it continues to have high hopes for CagriSema despite the latest setback.

For now, however, the results highlight the growing challenge Novo faces in keeping pace with Lilly in a market where incremental differences in weight loss can have major commercial consequences.

The post Novo stock drops 15% as obesity drug falls short in key trial appeared first on Invezz

US stock index futures declined on Monday as investors reacted to renewed tariff uncertainty after US President Donald Trump announced a new 15% global duty, even after a Supreme Court ruling struck down most of his earlier levies.

The Supreme Court, in a 6–3 decision on Friday, voided a large portion of tariffs imposed last year, finding the emergency law used by the administration did not authorize such measures.

The Court did not address potential refunds, leaving open the possibility of a roughly $170 billion gap in US finances.

Using a different statute, the administration first introduced a 10% tariff and then raised it to 15%, which could remain in place for up to five months while officials search for longer-term policy options.

Dow Jones Industrial Average futures down about 127 points, with S&P 500 and Nasdaq-100 futures also falling 0.25% to 0.4%, respectively.

Tariff policy clouds outlook

Markets had initially reacted positively to the court ruling, with the major indexes posting weekly gains on Friday.

The Nasdaq snapped a five-week losing streak, while the Dow gained more than 230 points and the S&P 500 rose about 0.7%.

However, the administration’s announcement of fresh duties quickly revived concerns about inflation, global trade, and economic growth.

The president said the tariffs would take effect immediately and warned that additional levies could follow in the coming months.

Oil prices also weakened, with Brent crude slipping about 0.5% to roughly $70.27 a barrel and US crude falling to around $66.28.

Bitcoin dropped below $65,000 at one point before recovering to $66,141, being down nearly 3% in the previous 24 hours.

Tech stocks, earnings and crypto movers

Most megacap and growth shares traded lower in premarket activity, though Alphabet rose about 0.5% after a gain in the prior session.

Nvidia fell 0.15% ahead of its earnings release later in the week on Wednesday, which investors are watching for signals on artificial intelligence spending.

High valuations and concerns about returns from large AI investments have recently pressured technology stocks.

Earnings from software companies, including Salesforce and Intuit, are also in focus as the S&P 500 software and services index has declined more than 20% this year.

Among individual movers, Eli Lilly rose 2.5% after rival Novo Nordisk’s obesity drug underperformed Lilly’s treatment in a Copenhagen trial.

Cryptocurrency-related equities weakened as bitcoin slipped.

Coinbase Global and Strategy (formerly known as Microstrategy) each fell more than 1%.

Precious metals and economic focus

Gold and silver mining stocks advanced alongside higher metal prices.

Newmont gained about 1%, while Hecla Mining rose roughly 1.8%.

Investors are also monitoring geopolitical developments and economic data releases, including durable goods orders and factory orders.

Meanwhile, tensions surrounding Iran and upcoming corporate earnings, particularly Nvidia’s results, remain key catalysts for markets in the days ahead.

The post S&P and Dow Jones futures fall as Trump tariffs revive uncertainty appeared first on Invezz

Domino’s Pizza reported stronger-than-expected fourth-quarter US same-store sales on Monday, as aggressive promotions and new menu launches helped draw budget-conscious diners, sending shares up about 5% in premarket trading.

The pizza chain, however, continues to face investor skepticism, with the stock hovering near its lowest level in more than two years amid broader concerns about consumer spending and the restaurant sector.

For the quarter ended in December, Domino’s posted net revenue of $1.54 billion, up 6.4% from a year earlier and ahead of analysts’ expectations of $1.52 billion.

Earnings rose 9.4% to $5.35 per share, slightly below Wall Street estimates of $5.38.

US momentum offsets softer international demand

Same-store sales in the United States increased 3.7% during the quarter, exceeding market expectations and underscoring the brand’s resilience in a challenging environment.

International comparable sales rose 0.7%, falling short of analysts’ projections of a 1.03% increase as demand remained soft in markets such as Australia and Japan.

The company opened a net 392 stores globally in the fourth quarter, helping lift global retail sales by 4.9% from a year earlier, excluding foreign currency impacts.

Chief executive Russell Weiner said the company’s “Hungry for MORE” strategy delivered gains across key metrics.

“In 2025 we demonstrated that when we execute our strategy it delivers more sales, more stores, and more profits,” he said in the earnings statement, noting that Domino’s gained another point of market share in the US pizza-restaurant category.

Consumer caution weighs on restaurant sector

The results come as US restaurants grapple with weaker discretionary spending.

Inflation has squeezed household budgets over the past two years, prompting many consumers, particularly in lower-income brackets, to cook more meals at home rather than dine out.

Even pizza, often seen as an affordable indulgence, has not been entirely immune.

Several chains have reported customers ordering less frequently.

Domino’s has largely bucked that trend by leaning into value-driven promotions.

The company’s “Best Deal Ever” offer, featuring a large pizza for $9.99, was a key driver of comparable sales growth in the second half of 2025, management said.

Rivals have adopted similar tactics.

McDonald’s and Yum Brands have rolled out value meals starting at $5 to attract cost-conscious diners, while higher-priced chains such as Chipotle Mexican Grill have reported sales declines amid softer traffic.

Menu innovation and digital push

Domino’s has also focused on menu innovation to drive traffic.

The launch of its Parmesan Stuffed Crust pizza was highlighted as a standout success, boosting both customer visits and average ticket sizes.

The company continues to invest in its digital platforms and loyalty programme, aiming to improve convenience and customer engagement.

Once reliant almost exclusively on its own delivery network, Domino’s has expanded partnerships with third-party delivery platforms in recent years to broaden its reach.

“We expect to meaningfully increase our market share within a US QSR pizza category that continues to grow,” Weiner said, though the company did not provide detailed financial guidance for 2026.

Dividend hike and valuation debate

The board approved a 15% increase in the quarterly dividend to $1.99 per share, payable on March 30, signalling confidence in cash flow generation.

Despite the solid quarterly performance, Domino’s shares have fallen nearly 16% over the past 12 months as investors remain wary about the durability of consumer spending.

Shares trade at roughly 22 times forward earnings, their lowest valuation in at least a decade.

BTIG analyst Peter Saleh reiterated a Buy rating, citing the stock’s compressed valuation.

He lowered his price target to $500 from $530 ahead of the results, implying roughly 30% upside from Friday’s close near $385.

Analysts polled by FactSet have a consensus target of $481.

Saleh noted that while management met prior targets, investors appear cautious about 2026 guidance and are bracing for potential moderation.

“Despite management’s success at achieving the target last year, investors are uneasy and have already assumed 2026 guidance will be below the promised range,” the analyst wrote on Friday.

The post Domino’s tops Q4 US sales estimates on value push, shares rise 5% appeared first on Invezz

Fastly stock price surged to its highest level since February 2024 as the company’s recovery accelerated. FSLY jumped to a high of $18.25, up by over 273% from its lowest level in 2025 as its turnaround gained steam. This recovery has pushed its market capitalization to over $2.7 billion.

Fastly stock has rebounded as the turnaround continues

Fastly is a top software company offering solutions to thousands of websites globally, such as Financial Times, Stripe, Wayfair, Guardian, and Airbnb.

The stock has rebounded in the past few days as the recent financial results showed that its business continued growing in the fourth quarter of last year.

Fastly’s revenue rose by 23% to $172.6 million, while its gross margin jumped to a record high of 61.4%. This revenue growth mirrored that of Cloudflare, a similar company that offers DNS solutions to thousands of companies.

Fastly’s annual revenue jumped to $624 million, while the Remaining Performance Obligations (RPO) jumped by 55% to $354 million. 

Most notably, the company boosted its forward guidance and now expects that its revenue will be between $168 million and $174 million, up by 18% YoY. It expects that the annual revenue will be between $700 million and $720 million, up by 14% YoY.

Fastly is benefiting from the ongoing demand from artificial intelligence (AI), with more companies using its platform to provide security to these companies. It is also benefiting from the ongoing growth of its total addressable market (TAM), which has jumped to over $22 billion.

Wall Street analysts have started boosting their Fastly stock targets. For example, Citigroup boosted its target from $10 to $13, while Royal Bank of Canada hiked the target to $12. DA Davidson and Piper Sandler analysts boosted their targets to $13 and $14. 

Therefore, the average estimate among all analysts covering the company is $12, much lower than the current $18. That is a sign that most analysts expect it to retreat in the coming months.

A likely reason for this is that analysts believe that the company is highly overvalued. For example, Fastly has a forward revenue growth of 11% and a net income margin of minus 19.5%, giving it a rule-of-40 metric of minus 8%. A negative rule-of-40 metric is a sign that a company is focusing on growth at the expense of its profits.

FSLY stock price technical analysis 

Fastly stock chart | Source: TradingView 

The weekly timeframe chart shows that the Fastly stock price has remained in a tight range in the past few months. It has remained between the key support at $5.04 and $25 since 2022.

The stock then rebounded recently, moving from to its highest level since February 2024. Its consolidation was part of the accumulation phase of the Wyckoff Theory.

Therefore, the stock may continue rising as bulls target the upper side of the range, potentially to the key resistance level at $25.50. A move above that level will point to more gains, potentially to the 23.6% Fibonacci Retracement level at $36.

The post Fastly stock price has soared: does it have more upside? appeared first on Invezz

For decades, Jeffrey Epstein’s Manhattan townhouse functioned as an unofficial annex to some of the world’s most powerful boardrooms.

Association with the financier was once treated as a marker of access and influence. That calculus has now reversed sharply.

The unsealing of millions of pages of Epstein-related court records and federal filings has transformed old connections into acute reputational risks.

Politicians, diplomats, financiers and corporate leaders are facing investigations, investor revolts and forced exits as fresh details of their ties to Epstein — a convicted sex offender who died in jail in 2019 — come into public view.

What was once dismissed as peripheral or historical contact has, in many cases, become career-ending.

DP World rocked by leadership exit

The latest high-profile casualty emerged on Friday, when Dubai-based logistics giant DP World announced the resignation of its group chair and chief executive, Sultan Ahmed bin Sulayem.

Bin Sulayem came under intense pressure following the publication of private messages exchanged with Epstein.

Sulayem sent an email to Jeffrey Epstein in September 2015 regarding a personal encounter with a woman he had met two years prior in Dubai.

In the message, Sulayem used highly graphic and objectifying language to describe her physical appearance and their intimate experience.

He noted that although she had been engaged, she had returned to him, and he characterized the encounter as the most significant of its kind he had ever experienced.

The fallout was swift.

Two of DP World’s largest international partners — Canada’s La Caisse pension fund and Britain’s development finance institution, British International Investment — said they would pause future investments with the group while reviewing governance concerns.

On Friday, post the resignation announcement, British International Investment said it would resume projects.

Bin Sulayem’s resignation underscores how swiftly institutional investors are now acting when reputational risk intersects with governance standards.

Goldman Sachs loses top lawyer

Just a day earlier, Goldman Sachs confirmed that its chief legal officer and general counsel, Kathy Ruemmler, would step down at the end of June.

Ruemmler’s decision followed revelations in the latest tranche of Epstein files showing extensive communication between the two from 2014 to 2019, long after Epstein’s 2008 guilty plea related to the exploitation of a minor.

The emails suggested a close personal relationship and included references to expensive gifts.

The disclosures also showed that Ruemmler had advised Epstein on responding to media inquiries in 2019 concerning allegations that he had received preferential legal treatment because of his connections.

While there is no suggestion that Ruemmler was involved in Epstein’s crimes, the optics proved untenable for a bank that has spent years reinforcing its governance and compliance credentials.

Barclays and the fall of Jes Staley

Perhaps the most prominent corporate casualty remains Jes Staley, the former chief executive of Barclays.

Staley, once regarded as one of the most influential figures in global banking, was forced to step down in late 2021 after UK regulators investigated how he had characterised his relationship with Epstein.

Staley maintained that he had no knowledge of Epstein’s criminal conduct, but thousands of emails exchanged between the two raised serious questions about the accuracy of disclosures made to regulators.

Barclays told the Financial Conduct Authority in 2019 that the pair did not have a close relationship and had not been in contact for years.

A subsequent investigation, drawing on around 1,200 emails obtained from JPMorgan, concluded that the bank had been misled.

More recent reporting by The Guardian has added to the controversy, citing documents that describe Staley as a trustee of Epstein’s estate until 2015 and outlining allegations of sexual misconduct.

There is no indication that prosecutors pursued those claims. Staley has denied wrongdoing and has not responded to repeated requests for comment, according to the newspaper.

Apollo and the price of proximity for Leon Black

The ripple effects of the Epstein disclosures have extended deep into the private equity world.

At Apollo Global Management, co-founder Leon Black stepped down as chairman in 2021 after an independent review revealed that he had paid Epstein $158 million for tax and estate planning advice after Epstein’s 2008 conviction.

While the review found no evidence that Black was involved in Epstein’s criminal conduct, the size of the payments triggered a backlash from institutional investors, underscoring how, in the ESG era, association alone can carry severe consequences.

Black’s exit as chairman came as a surprise.

When Apollo Global Management published an independent report in January 2021 examining his financial ties to Epstein, the firm said Black would remain chairman even after stepping down as chief executive upon turning 70 that July.

That plan changed months later, after Black told Apollo’s board in a March letter that the public scrutiny surrounding his dealings with Epstein had taken a toll on his health.

The external review, conducted by the law firm Dechert, detailed how Black had paid Jeffrey Epstein $158 million in fees and extended loans of nearly $30 million.

According to the report, Epstein — who died in August 2019 while facing federal sex trafficking charges — provided Black with advice on trust and estate planning, tax matters and issues linked to Black’s extensive art collection.

The review estimated that Epstein’s guidance may have saved Black up to $2 billion in taxes, a figure that intensified investor unease even as the inquiry cleared him of criminal wrongdoing.

JPMorgan’s settlement and questions facing Jamie Dimon

Banks that retained their leadership have not escaped unscathed.

JPMorgan Chase agreed to a $290 million settlement with Epstein’s victims, effectively acknowledging failures in its internal controls.

Epstein maintained more than 50 accounts at the bank between 1998 and 2013, holding hundreds of millions of dollars even after his 2008 conviction.

According to a New York Times investigation drawing on thousands of pages of internal bank records, sealed deposition transcripts, court documents, financial data, and interviews with people familiar with the relationship, JPMorgan officials spent more than a decade voicing concerns about Epstein’s frequent wire transfers and large cash withdrawals.

Despite repeated warnings to senior management — and even as the bank processed more than $1 billion in such transactions for him — top executives overrode those objections on at least four occasions over five years and kept Epstein as a client.

A JPMorgan report filed late with the Treasury Department identified about 4,700 Epstein-linked “suspicious activity” transactions worth roughly $1.1 billon, including payments to women in post-Soviet countries.

The issue has now taken on political dimensions.

President Donald Trump has called for prosecutors to examine Epstein’s ties to JPMorgan, raising questions over the legacy of the bank’s chief executive, Jamie Dimon.

“There’s got to be more accountability from the top on down,” the Democratic senator Ron Wyden, the powerful ranking member of the Senate Finance Committee, told The Guardian.

Epstein was not an anonymous customer with a few thousand bucks in his checking account; he was a high-value, high-profile client of white-glove private banks and a known criminal. It’s simply not good enough for leaders at those banks to say they never had an inkling that something was off.

The renewed scrutiny suggests the fallout from the Epstein disclosures is far from over.

As more documents are examined, the standard for acceptable proximity to disgraced figures is being redrawn — with profound consequences for corporate leadership and governance.

The post Epstein files spark boardroom resignations, and the fallout is spreading appeared first on Invezz